Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Quercioli, Alessandra ^a   Montecucco, Fabrizio ^a,b   Galan, Katia ^a   Ratib, Osman ^a   Roux Lombard, Pascale ^a   Pagano, Sabrina ^a   MacH, François ^a   Schindler, Thomas H ^a   Vuilleumier, Nicolas ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA N 13; APOLIPOPROTEIN A1 IMMUNOGLOBULIN G ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; APOLIPOPROTEIN A1; AUTOANTIBODY; IMMUNOGLOBULIN G;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COLD PRESSOR TEST; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ENDOTHELIAL DYSFUNCTION; DIAGNOSTIC IMAGING EQUIPMENT; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE BLOOD FLOW; HEMODYNAMIC PARAMETERS; HUMAN; MALE; METABOLIC PARAMETERS; OBESITY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; BLOOD; BLOOD VESSEL CALCIFICATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HEMODYNAMICS; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADULT; APOLIPOPROTEIN A-I; AUTOANTIBODIES; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; HEMODYNAMICS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; OBESITY; VASCULAR CALCIFICATION;

EID: 84870220327     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/243158     Document Type: Article

References (40)

1. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T. B., Flegal K., Ford E., Furie K., Go A., Greenlund K., Haase N., Hailpern S., Ho M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M., Meigs J., Mozaffarian D., Nichol G., O'Donnell C., Roger V., Rosamond W., Sacco R., Sorlie P., Stafford R., Steinberger J., Thom T., Wasserthiel-Smoller S., Wong N., Wylie-Rosett J., Hong Y., Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009 119 3 e21 e181 2-s2.0-60449094498 10.1161/CIRCULATIONAHA.108.191261
2. Ford E. S., Ajani U. A., Croft J. B., Critchley J. A., Labarthe D. R., Kottke T. E., Giles W. H., Capewell S., Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. New England Journal of Medicine 2007 356 23 2388 2398 2-s2.0-34250019702 10.1056/NEJMsa053935 (Pubitemid 46883773)
3. Wilson P. W. F., D'Agostino R. B., Levy D., Belanger A. M., Silbershatz H., Kannel W. B., Prediction of coronary heart disease using risk factor categories. Circulation 1998 97 18 1837 1847 2-s2.0-0032510639 (Pubitemid 28213628)
4. D'Agostino R. B., Vasan R. S., Pencina M. J., Wolf P. A., Cobain M., Massaro J. M., Kannel W. B., General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008 117 6 743 753 2-s2.0-39549093148 10.1161/CIRCULATIONAHA.107.699579 (Pubitemid 351640675)
5. Murphy T. P., Dhangana R., Pencina M. J., Zafar A. M., D'Agostino R. B., Performance of current guidelines for coronary heart disease prevention: optimal use of the Framingham-based risk assessment. Atherosclerosis 2011 216 2 452 457 2-s2.0-79957999651 10.1016/j.atherosclerosis.2011.02.020
6. Hanley J. A., McNeil B. J., The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982 143 1 29 36 2-s2.0-0020083498 (Pubitemid 12142173)
7. Nasir K., Michos E. D., Blumenthal R. S., Raggi P., Detection of high-risk young adults and women by coronary calcium and national cholesterol education program panel III guidelines. Journal of the American College of Cardiology 2005 46 10 1931 1936 2-s2.0-27644504593 10.1016/j.jacc.2005.07.052 (Pubitemid 41579818)
8. Johnson K. M., Dowe D. A., The detection of any coronary calcium outperforms framingham risk score as a first step in screening for coronary atherosclerosis. American Journal of Roentgenology 2010 194 5 1235 1243 2-s2.0-77951969650 10.2214/AJR.09.2487
9. Blaha M., Budoff M. J., Shaw L. J., Khosa F., Rumberger J. A., Berman D., Callister T., Raggi P., Blumenthal R. S., Nasir K., Absence of coronary artery calcification and all-cause mortality. Journal of the American College of Cardiology 2009 2 6 692 700 2-s2.0-66849104414 10.1016/j.jcmg.2009.03.009
10. Polonsky T. S., McClelland R. L., Jorgensen N. W., Bild D. E., Burke G. L., Guerci A. D., Greenland P., Coronary artery calcium score and risk classification for coronary heart disease prediction. Journal of the American Medical Association 2010 303 16 1610 1616 2-s2.0-77951639385 10.1001/jama.2010.461
11. Sarwar A., Shaw L. J., Shapiro M. D., Blankstein R., Hoffman U., Cury R. C., Abbara S., Brady T. J., Budoff M. J., Blumenthal R. S., Nasir K., Diagnostic and prognostic value of absence of coronary artery calcification. Journal of the American College of Cardiology 2009 2 6 675 688 2-s2.0-66449095849 10.1016/j.jcmg.2008.12.031
12. Schindler T. H., Schelbert H. R., Quercioli A., Dilsizian V., Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. Journal of the American College of Cardiology 2010 3 6 623 640 2-s2.0-77956658504 10.1016/j.jcmg.2010.04.007
13. Greenland P., Alpert J. S., Beller G. A., Benjamin E. J., Budoff M. J., Fayad Z. A., Foster E., Hlatky M. A., Hodgson J. M., Kushner F. G., Lauer M. S., Shaw L. J., Smith Jr. S. C., Taylor A. J., Weintraub W. S., Wenger N. K., 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. Journal of the American College of Cardiology 2010 56 25 e50 e103 2-s2.0-78650708490 10.1016/j.jacc.2010.09.001
14. Binder C. J., Chang M. K., Shaw P. X., Miller Y. I., Hartvigsen K., Dewan A., Witztum J. L., Innate and acquired immunity in atherogenesis. Nature Medicine 2002 8 11 1218 1226 2-s2.0-0036852824 10.1038/nm1102-1218 (Pubitemid 35373552)
15. Blasi C., The autoimmune origin of atherosclerosis. Atherosclerosis 2008 201 1 17 32 2-s2.0-53849105417 10.1016/j.atherosclerosis.2008.05.025
16. Packard R. R. S., Libby P., Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clinical Chemistry 2008 54 1 24 38 2-s2.0-38749112555 10.1373/clinchem.2007.097360 (Pubitemid 351182593)
17. Roux-Lombard P., Pagano S., Montecuco F., Satta N., Vuilleumier N., Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases. Clinical Reviews in Allergy and Immunology. In press 10.1007/s12016-010-8233-z
18. Vuilleumier N., Rossier M. F., Pagano S., Python M., Charbonney E., Nkoulou R., James R., Reber G., MacH F., Roux-Lombard P., Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction. European Heart Journal 2010 31 7 815 823 2-s2.0-77950489726 10.1093/eurheartj/ehq055
19. Vuilleumier N., Bas S., Pagano S., Montecucco F., Guerne P. A., Finckh A., Lovis C., Mach F., Hochstrasser D., Roux-Lombard P., Gabay C., Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. Arthritis and Rheumatism 2010 62 9 2640 2650 2-s2.0-77956386145 10.1002/art.27546
20. Finckh A., Courvoisier D. S., Pagano S., Bas S., Chevallier-Ruggeri P., Hochstrasser D., Roux-Lombard P., Gabay C., Vuilleumier N., Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? Arthritis Care and Research 2012 64 6 817 825 2-s2.0-84863871272 10.1002/acr.21631
21. Keller P.-F., Pagano S., Roux-Lombard P., Sigaud P., Rutschmann O. T., Mach F., Hochstrasser D., Vuilleumier N., Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction. Journal of Internal Medicine 2012 271 5 451 462 2-s2.0-84863738039 10.1111/j.1365-2796.2011.02479.x
22. Montecucco F., Vuilleumier N., Pagano S., Lenglet S., Bertolotto M., Braunersreuther V., Pelli G., Kovari E., Pane B., Spinella G., Pende A., Palombo D., Dallegri F., MacH F., Roux-Lombard P., Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability. European Heart Journal 2011 32 4 412 421 2-s2.0-79951839869 10.1093/eurheartj/ ehq521
23. Quercioli A., Pataky Z., Vincenti G., Makoundou V., Di Marzo V., Montecucco F., Carballo S., Thomas A., Staub C., Steffens S., Seimbille Y., Golay A., Ratib O., Harsch E., MacH F., Schindler T. H., Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. European Heart Journal 2011 32 11 1369 1378 2-s2.0-79958109354 10.1093/eurheartj/ehr029
24. Quercioli A., Mach F., Bertolotto M., Lenglet S., Vuilleumier N., Galan K., Pagano S., Braunersreuther V., Pelli G., Pistoia V., Bianchi G., Cittadini G., Viviani G. L., Pende A., Roux-Lombard P., Thomas A., Staub C., Ratib O., Dallegri F., Schindler T. H., Montecucco F., Receptor activator of NF- κ B ligand (RANKL) increases the release ofneutrophil products associated with coronary vulnerability. Thrombosis and Haemostasis 2012 107 1 124 139 2-s2.0-84855301507 10.1160/TH11-05-0324
25. Davignon J., Ganz P., Role of endothelial dysfunction in atherosclerosis. Circulation 2004 109 23, supplement 1 III27 III32 2-s2.0-2942733214 (Pubitemid 38786440)
26. Tounian P., Aggoun Y., Dubern B., Varille V., Guy-Grand B., Sidi D., Girardet J. P., Bonnet D., Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. The Lancet 2001 358 9291 1400 1404 2-s2.0-0035960440 10.1016/S0140- 6736(01)06525-4 (Pubitemid 33055740)
27. Quercioli A., Pataky Z., Montecucco F., Carballo S., Thomas A., Staub C., Di Marzo V., Vincenti G., Ambrosio G., Ratib O., Golay A., MacH F., Harsch E., Schindler T. H., Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. Journal of the American College of Cardiology 2012 5 8 805 815 2-s2.0-84865079899 10.1016/j.jcmg.2012.01.020
28. Valenta I., Quercioli A., Vincenti G., Nkoulou R., Dewarrat S., Rager O., Zaidi H., Seimbille Y., MacH F., Ratib O., Schindler T. H., Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT. Journal of Nuclear Cardiology 2010 17 6 1023 1033 2-s2.0-78651266821 10.1007/s12350-010-9272-9
29. Villines T. C., Hulten E. A., Shaw L. J., Goyal M., Dunning A., Achenbach S., Al-Mallah M., Berman D. S., Budoff M. J., Cademartiri F., Callister T. Q., Chang H.-J., Cheng V. Y., Chinnaiyan K., Chow B. J. W., Delago A., Hadamitzky M., Hausleiter J., Kaufmann P., Lin F. Y., Maffei E., Raff G. L., Min J. K., Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: an International Multicenter) registry. Journal of the American College of Cardiology 2011 58 24 2533 2540 2-s2.0-84866258454 10.1016/j.jacc.2011.10.851
30. Dilsizian V., Narula J., Atlas of Nuclear Cardiology 2009 3rd Current Medicine Group
31. Schindler T. H., Campisi R., Dorsey D., Prior J. O., Olschewski M., Sayre J., Schelbert H. R., Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors. European Heart Journal 2009 30 8 978 986 2-s2.0-65249177165 10.1093/eurheartj/ehp013
32. DeLong E. R., DeLong D. M., Clarke-Pearson D. L., Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988 44 3 837 845 2-s2.0-0023710206
33. Cornier M.-A., Després J.-P., Davis N., Grossniklaus D. A., Klein S., Lamarche B., Lopez-Jimenez F., Rao G., St-Onge M.-P., Towfighi A., Poirier P., Assessing adiposity: a scientific statement from the american heart association. Circulation 2011 124 18 1996 2019 2-s2.0-80855130499 10.1161/CIR.0b013e318233bc6a
34. Stofkova A., Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocrine Regulations 2009 43 4 157 168 2-s2.0-77949493588 10.4149/endo200904157
35. Batuca J. R., Ames P. R. J., Amaral M., Favas C., Isenberg D. A., Delgado Alves J., Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus. Rheumatology 2009 48 1 26 31 2-s2.0-57349119015 10.1093/rheumatology/ken397
36. Ames P. R. J., Matsuura E., Batuca J. R., Ciampa A., Lopez L. L., Ferrara F., Iannaccone L., Delgado Alves J., High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome. Lupus 2010 19 6 711 716 2-s2.0-77951215754 10.1177/0961203309357765
37. Farbstein D., Levy A. P., HDL dysfunction in diabetes: causes and possible treatments. Expert Review of Cardiovascular Therapy 2012 10 3 353 361 2-s2.0-77949546541 10.1586/erc.11.182
38. Scholtes V. P. W., Versteeg D., De Vries J. P. P. M., Hoefer I. E., Schoneveld A. H., Stella P. R., Doevendans P. A. F. M., Van Keulen K. J. K., De Kleijn D. P. V., Moll F. L., Pasterkamp G., Toll-like receptor 2 and 4 stimulation elicits an enhanced inflammatory response in human obese patients with atherosclerosis. Clinical Science 2011 121 5 205 214 2-s2.0-79961151517 10.1042/CS20100601
39. Kim S. J., Choi Y., Choi Y. H., Park T., Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. Journal of Nutritional Biochemistry 2012 23 113 122 2-s2.0-79952505312 10.1016/j.jnutbio.2010.10.012
40. Pagano S., Satta N., Werling D., Offord V., de Moerloose P., Charbonney E., Hochstrasser D., Roux-Lombard P., Vuilleumier N., Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. Journal of Internal Medicine 2012 272 4 344 357 2-s2.0-84863981183 10.1111/j.1365-2796.2012.02530.x